SENTARA OBICI HOSPITAL
1. Target Overview & Investment Thesis
SENTARA OBICI HOSPITAL is a 186-bed suburban community hospital in SUFFOLK CITY, VA with $329.1M in net patient revenue and a 15.1% operating margin. The hospital serves a payer mix of 32.3% Medicare, 2.4% Medicaid, and 65.2% commercial.
Thesis: Turnaround. Our ML models identify $24.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.1% to 22.5% (+736bps).
| Net Revenue HCRIS | $329.1M |
| Current EBITDA COMPUTED | $49.8M |
| Operating Margin COMPUTED | 15.1% |
| Occupancy HCRIS | 73.5% |
| Revenue / Bed COMPUTED | $1.8M |
| Net-to-Gross HCRIS | 26.7% |
| Distress Probability ML | 41.6% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 15.1% places it above the state median. Among 45 size-comparable peers (93-372 beds), the median margin is 5.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (93-372), prioritizing same-state peers. 45 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SENTARA OBICI HOSPITAL (Target) | VA | 186 | $329.1M | 15.1% |
| ST. MARYS HOSPITAL | VA | 363 | $688.9M | 13.3% |
| VIRGINIA HOSPITAL CENTER ARLIN | VA | 336 | $624.4M | 1.8% |
| CHILDRENS HOSPITAL OF THE KING | VA | 202 | $546.2M | -9.9% |
| SENTARA LEIGH HOSPITAL | VA | 274 | $511.5M | 14.7% |
| INOVA LOUDOUN HOSPITAL CENTER | VA | 189 | $510.3M | 22.9% |
| INOVA ALEXANDRIA HOSPITAL | VA | 303 | $456.5M | 26.3% |
| SENTARA VA. BEACH GENERAL HOSP | VA | 239 | $443.9M | 15.2% |
| SENTARA RMH MEDICAL CENTER | VA | 238 | $408.3M | -22.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $24.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $6.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $6.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $211K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $49.8M |
| + RCM Uplift | +$24.2M |
| Pro Forma EBITDA | $74.0M |
| Current Margin | 15.1% |
| Pro Forma Margin | 22.5% |
| WC Released (1x) | $12.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $76.6M | $570.7M | 7.45x | 49.4% |
| Base (11x exit) | 10.0x | 11.0x | $76.6M | $652.7M | 8.52x | 53.5% |
| Bull Case | 9.0x | 11.0x | $68.9M | $757.5M | 10.99x | 61.5% |
| Bull (12x exit) | 9.0x | 12.0x | $68.9M | $846.7M | 12.28x | 65.1% |
| Bear Case | 11.0x | 10.0x | $84.3M | $424.7M | 5.04x | 38.2% |
| Bear (11x exit) | 11.0x | 11.0x | $84.3M | $494.5M | 5.87x | 42.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 45 hospitals with 93-372 beds
- Same-state prioritization (n=46)
- Comp margins: P25=-3.9% / P50=5.2% / P75=14.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.